← Eichor
Study identifier: NCT03451916 Synced from ClinicalTrials.gov · July 30, 2026
● Completed

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Condition: Hip Fracture  ·  Sponsor: Pluristem Ltd.

PhasePhase 3
Planned participants240
Who can joinAll sexes, 0 Years to 90 Years
Healthy volunteersNo

About this study

The objectives of this study are to assess the efficacy, safety, and tolerability of PLX-PAD intramuscular administration for the treatment of muscle injury following arthroplasty for HF.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (17)

University Of California Davis,4860 Y StreetSacramento, California, United States
Denver Metro Orthopedics, P.C. 499 E. Hampden Avenue, Suite 140 Englewood, CO 80113Denver, Colorado, United States
ANTRIA, INC,300 Indian Springs Road,IndianaIndiana, Pennsylvania, United States
MHAT "Ljulin" Department of Orthopedy and TraumatologySofia, Bulgaria
MHAT "Serdika" Department of Orthopedy and TraumatologySofia, Bulgaria
Military Medical AcademySofia, Bulgaria
Specialized Hospital for Active Treatment in OrthopedySofia, Bulgaria
Charite - Campus Mitte,Campus Virchow-KlinikumBerlin, Germany
Universitaetsklinikum Carl Gustav Carus an der Technischen Universitaet DresdenDresden, Germany
Universitaetsklinikum MuensterMünster, Germany
Carmel Medical Center,7 Michal StHaifa, Israel
Shaare Zedek Medical Center,The Orthopedic Department,Shmu'el Bait St. 12Jerusalem, Israel

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03451916